Integral Health Asset Management »

Arrowhead Pharmaceuticals shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.8M 225k 34.49
2025-03-31 $2.2M 175k 12.74
2024-12-31 $5.2M 275k 18.80
2021-12-31 $3.3M 50k 66.30
2020-12-31 $3.8M 50k 76.74

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
FMR
Slate Path Capital
Geode Capital Management
Siren
Driehaus Capital Management
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Ubs Global Asset Management Americas
Morgan Stanley
Baker Bros. Advisors
Marshall Wace

View all funds holding Arrowhead Pharmaceuticals